BlackRock Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$111M Buy
3,075,439
+178,716
+6% +$7.14M 0.05% 395
2016
Q3
$133M Sell
2,896,723
-721,705
-20% -$37.7M 0.07% 339
2016
Q2
$182M Buy
3,618,428
+176,534
+5% +$9.4M 0.09% 260
2016
Q1
$184M Sell
3,441,894
-734,241
-18% -$43.1M 0.1% 243
2015
Q4
$274M Buy
4,176,135
+137,154
+3% +$8.48M 0.15% 153
2015
Q3
$228M Sell
4,038,981
-366,853
-8% -$23.8M 0.13% 179
2015
Q2
$260M Buy
4,405,834
+233,831
+6% +$14.4M 0.14% 173
2015
Q1
$260M Buy
4,172,003
+418,458
+11% +$24.3M 0.14% 174
2014
Q4
$216M Buy
3,753,545
+977,837
+35% +$54.5M 0.12% 201
2014
Q3
$149M Buy
2,775,708
+590,214
+27% +$31.3M 0.09% 266
2014
Q2
$115M Buy
2,185,494
+361,387
+20% +$18.5M 0.07% 341
2014
Q1
$96.4M Buy
1,824,107
+1,559,507
+589% +$72.1M 0.06% 366
2013
Q4
$10.6M Sell
264,600
-233,800
-47% -$9.21M 0.01% 904
2013
Q3
$18.8M Buy
498,400
+272,600
+121% +$10.6M 0.01% 776
2013
Q2
$8.85M Buy
+225,800
New +$8.79M 0.01% 889

Other funds holding TEVA